Phase Ib/II trials of BEBT-109 in advanced NSCLC with EGFR exon 20 insertion mutations

BEBT-109 - BeBetter Med

https://oncologypro.esmo.org/congress-resources/esmo-asia-congress-2025?presentation=phase_ib_ii_trials_of_bebt_109_in_advanced_nsclc_w

Y. Wu1; C. Qian2; Y. Zhang3; H. Tu1; L. Xing4; Z. Wang5; Y. Jia6; G. Jiang6; X. Dong7; H. Wang8; F. Luo9; Z. Liu10; Y. Luo11; S. Ma12; Q. Bu13; C.S. Ye14

Oct 4, 2025